Skip to main content

An official website of the United States government

You have 2 new alerts

Posting of the DRFP2 Comments for the National Cancer Institute’s (NCI) supporting the NCI Federally Funded Research and Development Center (FFRDC)/Frederick National Laboratory for Cancer Research (FNLCR)

General Information

  • Contract Opportunity Type: Special Notice (Original)
  • Original Published Date: May 13, 2022 03:33 pm EDT
  • Original Response Date: May 30, 2022 04:00 pm EDT
  • Inactive Policy: 15 days after response date
  • Original Inactive Date:
  • Initiative:
    • None

Classification

  • Original Set Aside:
  • Product Service Code:
  • NAICS Code:
  • Place of Performance:

Description

PURPOSE:

THIS IS A SPECIAL NOTICE. This is NOT a solicitation for proposals, proposal abstracts, or quotations. The purpose of this Special Notice is to provide responses to questions received in response to the second Draft RFPs released on 4 February 2022. Please find the document entitled “DRFP2 QA Final” attached.

ADDITIONAL INFORMATION:

Additional information concerning the competitive process for the contract will be announced on https://beta.sam.gov/ as well as at the FNLCR Acquisition Portal: https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/. The information posted to Beta SAM takes precedence over information provided elsewhere and serves as the Government’s official government-wide point of entry (GPE).

If you have questions, please email the FNLCR Acquisition Team at: FNLCR_ACQinfo@nih.gov  (FNLCR_ACQinfo@nih.gov).

Contact Information

Contracting Office Address

  • OFFICE OF ACQUISITIONS 31Center Dr. 11A35P
  • Bethesda , MD 20892
  • USA

Primary Point of Contact

Secondary Point of Contact

History

  • Jun 14, 2022 11:55 pm EDTSpecial Notice (Original)